Skip to content

Manuel Dómine

Universidad de Las Palmas de Gran Canaria

2 papers in the Anchorcite directory, published between 2015 and 2018, cited 15,305 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Marina Chiara Garassino · 2 papers
  • Julie Renee Brahmer · 1 paper
  • Karen L. Reckamp · 1 paper
  • Lucio Crinò · 1 paper
  • Wilfried Eberhardt · 1 paper
  • Elena V Poddubskaya · 1 paper
  • Scott Joseph Antonia · 1 paper
  • Adam Płużański · 1 paper

Papers

  1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung CancerNew England Journal of Medicine · 2015 · 8,551 citations

    BACKGROUND: Patients with advanced squamous-cell non-small-cell lung cancer (NSCLC) who have disease progression during or after first-line chemotherapy have limited treatment options. This randomized, open-label, international, phase 3 study evaluated the efficacy and safety of nivolumab, a fully human IgG4…

  2. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung CancerNew England Journal of Medicine · 2018 · 6,754 citations

    BACKGROUND: First-line therapy for advanced non-small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportion score for programmed death ligand 1 (PD-L1) of 50% or greater, pembrolizumab has replaced cytotoxic chemotherapy as the…

Metadata from OpenAlex (CC0).